Strategies for clinical implementation of TNM-Immunoscore in resected nonsmall-cell lung cancer.
about
Towards tumor immunodiagnosticsEmerging roles of T helper 17 and regulatory T cells in lung cancer progression and metastasisHeterogeneity of CD8+ tumor-infiltrating lymphocytes in non-small-cell lung cancer: impact on patient prognostic assessments and comparison of quantification by different sampling strategiesImportance of tumor infiltrating lymphocytes in non-small cell lung cancer?Analysis of the immune microenvironment in resected non-small cell lung cancer: the prognostic value of different T lymphocyte markers.Prognostic effect of intratumoral neutrophils across histological subtypes of non-small cell lung cancer.The biology of uveal melanomaAnalysis of the prognostic role of an immune checkpoint score in resected non-small cell lung cancer patients.Immunotherapeutic strategies for the treatment of renal cell carcinoma: Where will we go?Are tumor-infiltrating lymphocytes protagonists or background actors in patient selection for cancer immunotherapy?Aligning Digital CD8(+) Scoring and Targeted Next-Generation Sequencing with PD-L1 Expression: A Pragmatic Approach in Early-Stage Squamous Cell Lung Carcinoma.Alteration of PD-L1 expression and its prognostic impact after concurrent chemoradiation therapy in non-small cell lung cancer patients.Programmed cell death-ligand 1 expression and immunoscore in stage II and III non-small cell lung cancer patients receiving adjuvant chemotherapy.CTLA-4 expression in the non-small cell lung cancer patient tumor microenvironment: diverging prognostic impact in primary tumors and lymph node metastases.Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract CaBeyond PD-L1 testing-emerging biomarkers for immunotherapy in non-small cell lung cancer.Changes in PD-L1 expression according to tumor infiltrating lymphocytes of acquired EGFR-TKI resistant EGFR-mutant non-small-cell lung cancer.Development of a reliable and accurate algorithm to quantify the tumor immune stroma (QTiS) across tumor types.Putative predictors of efficacy for immune checkpoint inhibitors in non-small-cell lung cancer: facing the complexity of the immune system.Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in ITreatment redirection from cure to palliation, then cure again?-a cautious, but urgent matter.Prognostic significance of immune cells in non-small cell lung cancer: meta-analysis.Immune Prophets of Lung Cancer: The Prognostic and Predictive Landscape of Cellular and Molecular Immune Markers
P2860
Q26738691-83810993-C218-4E97-A5DF-84253870FCC9Q28069422-AB899E02-BEF3-455C-9673-0BDE01D856CDQ30275647-94AA7DC4-C04E-4B86-9004-E3C11DAA7A92Q36829208-B9C098CA-3EE1-49CF-96A1-E1968AC420E4Q37619675-C0837227-D3B8-4E0E-B832-7321D7C7F945Q37687799-791E8BB9-E876-4658-8AA6-3745A6993934Q37742632-5A471D16-49D1-406D-A751-9C0FFF5433C6Q38961444-D7B12E2F-C653-41A1-A67B-A3C9485AB817Q39120161-9B24A269-5CD6-4479-8E68-8F1FFB5DF297Q39187442-E34806EF-4D38-4477-92A0-F8994D50AE16Q40496586-E378DD0E-C0DC-4A00-8F0B-0D0A7C3EC3B4Q41201725-0480916E-ABB7-4787-AEDB-996E44B17F49Q42365288-34D095CA-94D3-4443-9B0A-D196660C61A0Q42683596-57CDDEB9-946B-40BD-A1F5-A4F28B931676Q46540302-598772E3-53F3-4055-B5BE-C4D49E82F8DAQ47101079-FCCC550B-D226-49A2-9C4D-64407801191DQ47107969-F1004FE1-43A9-450A-B5F0-A08672B2DEE3Q47554538-51B1C76B-C102-4CD1-8459-1CF25F3FAD3CQ50070316-D180886C-2B01-453C-A31D-86DC411CE83AQ54685474-787B7DA6-4C50-4AE3-8A48-111A6E27E7E8Q55024912-EBE175EE-4FED-4D50-871F-23B0278B6262Q55440274-74536020-36F4-45F0-964A-8620C8FB4A17Q56892179-78036444-85F4-4D60-971E-A740C1E1E46A
P2860
Strategies for clinical implementation of TNM-Immunoscore in resected nonsmall-cell lung cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Strategies for clinical implem ...... ted nonsmall-cell lung cancer.
@en
type
label
Strategies for clinical implem ...... ted nonsmall-cell lung cancer.
@en
prefLabel
Strategies for clinical implem ...... ted nonsmall-cell lung cancer.
@en
P2093
P2860
P50
P356
P1433
P1476
Strategies for clinical implem ...... ted nonsmall-cell lung cancer.
@en
P2093
B H Gronberg
E E Paulsen
E Richardsen
F Pezzella
K Al-Shibli
L Helgeland
L T Busund
M Lund-Iversen
P2860
P304
P356
10.1093/ANNONC/MDV560
P577
2015-11-16T00:00:00Z